Dark Horse Comics' May 2024 Solicitations Featuring Josh Gad, Neil Gaiman, and Brian Bendis

Dark Horse Comics is gearing up for a thrilling new month of comic book releases! This May, dive into new stories about hauntings, space exploration, and even alien invasions. From the return of classic series to brand-new titles, there's something for every kind of comic book fan. Get your long boxes ready for these exciting new issues!

This May, Dark Horse Comics is kicking off with several notable new releases. Top talent such as Neil Gaiman, Brian Bendis, and Josh Gad are bringing their unique vision to the page with new stories and thrilling continuations of their beloved series. Whether you're a fan of horror, sci-fi, or superheroes, there's something for everyone to enjoy this month.

Among the standout titles is "Writer #1," a new series written by Josh Gad and drawn by Ariel Olivetti. The four-issue series explores the dark and terrifying world of a writer whose life spirals into a nightmare orchestrated by legendary figures. Next up is "Anansi Boys" adapted from the novel by Neil Gaiman, which follows the story of "Fat" Charlie Nancy, a boring Londoner whose father was Anansi the Spider, the trickster god of African folklore. Also, be sure to check out "Resident Alien: The Book of Life," which follows the continuing adventures of Harry as he confronts life and death and love and loss.

Additionally, Dark Horse is excited to present "Canto: A Place Like Home" by David M. Booher and Drew Zucker, which marks the finale of the Shrouded Man Saga. Canto and his allies must rally together to take down the evil sorcerer before he conquers Canto's people. Also, Zac Thompson and Hayden

Read more

Prospective observational study of peripheral intravenous cannula utilisation and frequency of intravenous fluid delivery in the emergency department: convenience or necessity?

Introduction Over one billion peripheral intravenous cannulas (PIVCs) are inserted worldwide each year. Insertion of PIVCs is associated with pain, phlebitis, occlusion, and medication extravasation as well as the risk of catheter-associated infection, with an associated cost to departmental resources. Previous studies have not assessed if intravenous (IV) fluid delivery